EMCDDA and Europol raise concerns on the threats of highly potent synthetic substances and the need to invest in harm reduction approaches, as one of the policy options to address the drug situation in Europe.
Niaah et al. lead an issue of Caribbean Quarterly, offering insights into the regional cannabis landscape, exploring policy and regulatory challenges and opportunities, socio-cultural significance, and many other dimensions.
The INCB analyses the world drug situation in relation to drug control policies, noting growing reforms toward legally regulated markets for non-medical purposes.
Kalicum et al. find that enrolling in an unsanctioned compassion club reduced all non-fatal overdose, pointing to the importance of this community-led intervention.
Dertadian explores how prohibitionist policies serve as a colonial tool and calls to centre the experiences and knowledges of Indigenous and colonised peoples in drug policy scholarship.
Ciro et al. reflect on how the legal regulation of drug markets in Colombia may act as reparations for past inequality and harm, and advance the interconnection of drug policy reform and reparative justice.
The Eastern and Central European and Central Asian Commission on Drug Policy calls to attention the external and internal elements affecting the drug situation in the region, and highlights opportunities for effective and humane drug policy reform.
C-EHRN explore the various challenges harm reduction workers encounter in their work and how those challenges affect them and their organisations, as well as coping mechanisms and organisational opportunities for support.
C-EHRN reports on the challenges faced and good practices by civil society organisations in Finland, Ireland, Greece and Hungary as they engage their governments in drug policy reform.
